Clinical Trials in California

Showing 5281-5300 of 8,631 trials

Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study

NCT02806024

The purpose of this pilot study is to determine if intravenous tranexamic acid (TXA) is effective for reducing blood loss during high risk surgical procedures related to placenta previa and placenta accreta. TXA is currently used in other types of surgery for patients who are expected to have a large blood loss, such as orthopedic or open heart surgery.

Placenta AccretaPostpartum HemorrhageCesarean Section+1 more

University of California, San Francisco14 participantsStarted Nov 2016

Fresno, California, United States

COMPLETEDPhase 344 miles

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

NCT02096263

The purpose of this study is to assess the immunogenicity and safety of GSK Biologicals' Infanrix hexa vaccine when administered to healthy infants as primary vaccination at 2, 4 and 6 months of age, co-administered with Prevnar and Rotarix with a booster dose of GSK Biologicals' Infanrix and Hiberix vaccines at 15-18 months of age.

PoliomyelitisDiphtheriaHaemophilus Influenzae Type b+3 more

GlaxoSmithKline585 participantsStarted Apr 2014

Tucson, Arizona, United States • Fayetteville, Arkansas, United States • Anaheim, California, United States +40 more locations

Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

Find Trials by Condition in California

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis

Post Market Surveillance Study of the Wingspan Stent System

Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes

Safety and Efficacy of PRP for Treatment of Disc Pain

Design Validation of Senofilcon A With New UV-blocking Additive

HW006 LATERAL Thoracotomy

Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer

ImageReady(TM) MR Conditional Pacing System Clinical Study

Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC

Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects

Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer

MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis

ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer

Trial of Simplified Treatment Monitoring for 8 Weeks Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients

A Clinical Trial of IntensiVE Dialysis